Interesting to see Recce say future costs will be covered by the R&D rebate.
At 30 June 2024 they owed almost $10 million for advances they had received in relation to R&D rebates from Radium capital.
To cover that debt they would need $23 million in R&D expenditure!!!
Can't see much left for other expenditure once they repay Radium Capital!!!!
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
RCE
recce pharmaceuticals ltd
Add to My Watchlist
4.62%
!
31.0¢

Interesting to see Recce say future costs will be covered by the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
-0.015(4.62%) |
Mkt cap ! $87.95M |
Open | High | Low | Value | Volume |
32.5¢ | 33.0¢ | 30.5¢ | $50.82K | 161.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 31943 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 9686 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 31420 | 0.305 |
7 | 32359 | 0.300 |
3 | 10523 | 0.295 |
11 | 90433 | 0.290 |
3 | 223000 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 10059 | 2 |
0.315 | 28921 | 1 |
0.320 | 523 | 1 |
0.325 | 523 | 1 |
0.330 | 93238 | 1 |
Last trade - 15.48pm 18/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online